Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management

NCT02094963 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Angina Pectoris

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

Seung-Jung Park

Collaborators

[object Object]